[Elsevier] Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1-2, open-label, multicohort trial

Marilena Post time 2024-4-24 22:10:15 | Show all posts |Read mode
Reward10points




Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
NORANISAH Post time 2024-4-24 22:10:16 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report


Junior Member
  • post

  • reply

  • points

    190

Latest Reply



Return to the list